Clinical trial
A Phase II Study of the Safety and Efficacy of E7820 Plus Cetuximab in…
NCT00309179 · Eisai Inc., Industry · Completed
Key facts
| NCT number | NCT00309179 |
|---|---|
| Title | A Phase II Study of the Safety and Efficacy of E7820 Plus Cetuximab in Colorectal Cancer, Preceded by a Run-in Study in Advanced Solid Tumors |
| Official title | A Single Arm Phase II Study of the Efficacy, Safety, and Biomarkers of Activity of E7820 Plus Cetuximab in Advanced Solid Tumors Preceded by a Run-In Study to Determine Safety of the Combination |
| Lead sponsor | Eisai Inc., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Advanced Colorectal Cancer |
| Intervention type | Drug |
| Interventions | E7820 plus cetuximab |
| Enrollment | 41 |
| Start date | Sep 24, 2007 |
| Primary completion | Dec 14, 2009 |
| Completion | Feb 13, 2017 |
| First posted | Mar 31, 2006 |
| Last update posted | Sep 14, 2017 |
| Countries | Canada, United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: